title: The ACUTE trial. Transesophageal echocardiography to guide electrical cardioversion in atrial fibrillation. Assessment of Cardioversion Using Transesophageal Echocardiography.
abstract: The Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) trial compared cardioversion following transesophageal echocardiography (TEE) against conventional management of atrial fibrillation (ie, cardioversion following 3 weeks of anticoagulation) in patients scheduled to undergo electrical cardioversion.
authors.affiliation: Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, OH 44195, USA.
authors.forename: Craig R
authors.initials: CR
authors.lastname: Asher
authors.forename: Allan L
authors.initials: AL
authors.lastname: Klein
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000628:therapy*; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D003663:Decision Trees; D017548:Echocardiography, Transesophageal; D004554:Electric Countershock / Q000009:adverse effects / Q000379:methods*; D004617:Embolism / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D017063:Outcome Assessment, Health Care; D016032:Randomized Controlled Trials as Topic; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D014859:Warfarin